SCHEMBL8520179

SCHEMBL8520179

O=P(O)(CCc1cccc2[nH]ccc12)Oc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.39
FAAH O00519 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PARP1 P09874 1/20 0.37
DAO P14920 1/20 0.37
MCL1 Q07820 1/20 0.37
GLS O94925 2/20 0.36
RHEB Q15382 3/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7634441 0.84 FAAH (0.54) FAAHCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL8058845 0.80 HPGDS (0.37) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8520737 0.79 ACP3 (0.53) SRCCYP1A2MCL1MAPTNPC1
SCHEMBL7606891 0.77 PARP1 (0.42) PARP1DAOMCL1GLSHDAC1
SCHEMBL7609680 0.74 FAAH (0.49) FAAHCYP3A4MEN1KMT2AALDH1A1
SCHEMBL8048486 0.73 ACP3 (0.49) SRCCYP1A2MCL1MAPT
SCHEMBL7639813 0.72 ACP3 (0.48) SRCCYP1A2MCL1MAPT
SCHEMBL27644456 0.71 PARP1 (0.68) SRCCYP2C19PARP1DAOGLS
SCHEMBL3245338 0.71 SRC (0.61) SRCCYP2C9CYP2C19ALDH1A1
SCHEMBL6536568 0.70 AHR (0.47) CYP1A2CYP3A4CYP2D6PARP1DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0949922-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-10-20 EP disclosed
WO-1998013044-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1998-04-02 WO disclosed